Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 253 to 254 of 254 entries
Sorted by: Best Match Show Resources per page
Performance evaluation of implantable cardioverter-defibrillators with SmartShock technology in patients with inherited arrhythmogenic diseases.

International journal of cardiology

Auricchio A, Sterns LD, Schloss EJ, Gerritse B, Lexcen DR, Molan AM, Kurita T.
PMID: 34998948
Int J Cardiol. 2022 Jan 06; doi: 10.1016/j.ijcard.2022.01.007. Epub 2022 Jan 06.

BACKGROUND: Patients with inherited arrhythmogenic diseases (IADs) are often prescribed preventative implantable cardioverter-defibrillators (ICDs) to manage their increased sudden cardiac arrest risk. However, it has been suggested that ICDs in IAD patients may come with additional risk. We aimed...

Cite
Auricchio A, Sterns LD, Schloss EJ, et al. Performance evaluation of implantable cardioverter-defibrillators with SmartShock technology in patients with inherited arrhythmogenic diseases. Int J Cardiol. 2022;doi: 10.1016/j.ijcard.2022.01.007.
Auricchio, A., Sterns, L. D., Schloss, E. J., Gerritse, B., Lexcen, D. R., Molan, A. M., Kurita, T. (2022). Performance evaluation of implantable cardioverter-defibrillators with SmartShock technology in patients with inherited arrhythmogenic diseases. International journal of cardiology, . https://doi.org/10.1016/j.ijcard.2022.01.007
Auricchio, Angelo, et al. "Performance evaluation of implantable cardioverter-defibrillators with SmartShock technology in patients with inherited arrhythmogenic diseases." International journal of cardiology vol. (2022). doi: https://doi.org/10.1016/j.ijcard.2022.01.007
Auricchio A, Sterns LD, Schloss EJ, Gerritse B, Lexcen DR, Molan AM, Kurita T. Performance evaluation of implantable cardioverter-defibrillators with SmartShock technology in patients with inherited arrhythmogenic diseases. Int J Cardiol. 2022 Jan 06; doi: 10.1016/j.ijcard.2022.01.007. Epub 2022 Jan 06. PMID: 34998948.
Copy Download .nbib Format: NLM
Distal feeding-bowel stimulation to treat short-term or long-term pathology: a systematic review.

Frontline gastroenterology

Dilke SM, Gould L, Yao M, Souvatzi M, Stearns A, Ignjatovic-Wilson A, Tozer P, Vaizey CJ.
PMID: 34917326
Frontline Gastroenterol. 2020 Aug 18;12(7):677-682. doi: 10.1136/flgastro-2019-101359. eCollection 2021.

BACKGROUND: Distal feeding (DF) describes the insertion of a feeding tube into a fistula or stoma to administer a liquid feed into the distal bowel. It is currently used clinically in patients who are unable to absorb enough nutrition...

Cite
Dilke SM, Gould L, Yao M, et al. Distal feeding-bowel stimulation to treat short-term or long-term pathology: a systematic review. Frontline Gastroenterol. 2020;12(7):677-682doi: 10.1136/flgastro-2019-101359.
Dilke, S. M., Gould, L., Yao, M., Souvatzi, M., Stearns, A., Ignjatovic-Wilson, A., Tozer, P., & Vaizey, C. J. (2021). Distal feeding-bowel stimulation to treat short-term or long-term pathology: a systematic review. Frontline gastroenterology, 12(7), 677-682. https://doi.org/10.1136/flgastro-2019-101359
Dilke, Stella Maye, et al. "Distal feeding-bowel stimulation to treat short-term or long-term pathology: a systematic review." Frontline gastroenterology vol. 12,7 (2021): 677-682. doi: https://doi.org/10.1136/flgastro-2019-101359
Dilke SM, Gould L, Yao M, Souvatzi M, Stearns A, Ignjatovic-Wilson A, Tozer P, Vaizey CJ. Distal feeding-bowel stimulation to treat short-term or long-term pathology: a systematic review. Frontline Gastroenterol. 2020 Aug 18;12(7):677-682. doi: 10.1136/flgastro-2019-101359. eCollection 2021. PMID: 34917326; PMCID: PMC8640400.
Copy Download .nbib Format: NLM
Showing 253 to 254 of 254 entries